Naloxone (Narcan® and Other Brands)

The Wisconsin Naloxone Multi-Award Vehicle is a state-wide contract designed to facilitate the procurement of critical overdose reversal medications, specifically Naloxone (Narcan® and other brand variants). The vehicle covers multiple pharmaceutical categories related to adrenergic blocking agents and anti-abuse drugs, enabling state agencies, local governments, and potentially authorized healthcare organizations to efficiently acquire life-saving overdose intervention medications. The contract encompasses various UNSPSC codes addressing different pharmaceutical classifications, including adrenergic blocking agent amino alcohols, bradykinin derivatives, and ethanolamines, which ensures comprehensive coverage of Naloxone product types.

The contract is administered by the Wisconsin Department of Administration and was awarded on September 1, 2020, with specific details regarding the period of performance not provided in the source data. The vehicle is statewide in scope, focusing on Wisconsin's geographic region and categorized under the NIGP code for Autonomic Drugs. While specific prime contractors are not listed in the provided information, the contract is structured to support critical public health interventions by streamlining the procurement process for Naloxone and related overdose reversal medications across state and local government entities.